Induction of labour with a favourable cervix and/or pre-labour rupture of membranes

Best Practice and Research: Clinical Obstetrics and Gynaecology

Volumn 17, Issue 5, 2003, Pages 795-809

  Crane, Joan M G ^a   Young, David C ^b  

^a MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Induction; Labour; Meta analysis; Misoprostol; Premature rupture of membranes; Prostaglandins

Indexed keywords

ANTIBIOTIC AGENT; MISOPROSTOL; NONSTEROID ANTIINFLAMMATORY AGENT; OXYTOCIN; PLACEBO; PROSTAGLANDIN; PROSTAGLANDIN E2;

AMNIOTOMY; ANTIBIOTIC THERAPY; CHORIOAMNIONITIS; CLINICAL TRIAL; COST BENEFIT ANALYSIS; DIARRHEA; DRUG COST; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG INFUSION; ENDOMETRITIS; EPIDURAL ANESTHESIA; FETUS ELECTROCARDIOGRAPHY; GYNECOLOGICAL EXAMINATION; HOSPITAL ADMISSION; HUMAN; LABOR INDUCTION; MEDICAL RESEARCH; META ANALYSIS; MUSCLE HYPERTONIA; NAUSEA; NAUSEA AND VOMITING; NEWBORN CARE; NEWBORN INFECTION; NEWBORN INTENSIVE CARE; OBSTETRIC ANALGESIA; OBSTETRIC ANESTHESIA; PATIENT SATISFACTION; PERINATAL DEATH; POSTPARTUM HEMORRHAGE; PREMATURE FETUS MEMBRANE RUPTURE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SIDE EFFECT; TREATMENT OUTCOME; TREATMENT PLANNING; ULCER; UTERINE CERVIX; UTERUS DISEASE; VAGINAL DELIVERY; VOMITING;

EID: 0141607202     PISSN: 15216934     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1521-6934(03)00067-1     Document Type: Review

References (98)

1. Gunn GC, Mishell Jr. DR & Morton DG. Premature rupture of fetal membranes: A review. American Journal of Obstetrics and Gynecology 1970; 106: 469-483.
2. Mozurkewich E. Management of premature rupture of membranes at term: An evidence based approach. Clinical Obstetrics and Gynecology 1999; 42: 749-756.
3. Premature rupture of membranes. American College of Obstetricians and Gynecologists Practice Bulletin Number 1, June 1998.
4. Polzin WJ & Brady K. The etiology of premature rupture of the membranes. Clinical Obstetrics and Gynecology 1998; 41: 810-816.
5. Skinner SJM, Campos GA & Liggins GC. Collagen content of human amniotic membranes: Effect of gestation length and premature rupture. Obstetrics and Gynecology 1981; 57: 487-489.
6. Lavery JP, Miller CE, Knight RD. The effect of labor on the rheologic response of chorioamniotic membranes. Obstetrics and Gynecology 1982; 60: 87-92.
7. Artal R, Sokol RJ, Neuman M et al. The mechanical properties of prematurely and nonprematurely ruptured membranes. American Journal of Obstetrics and Gynecology 1976; 125: 655-659.
8. Hannah ME, Ohlsson A, Farine D et al. Induction of labor compared with expectant management for prelabor rupture of the membranes at term. New England Journal of Medicine 1996; 334: 1005-1010.
9. Tan BP, Hannah ME. Oxytocin for pre-labour rupture of membranes at or near term (Cochrane Review). In The Cochrane Library, Issue 4, Oxford: Update Software, 2002.
10. Tan BP, Hannah ME. Prostaglandins for pre-labour rupture of membranes at or near term (Cochrane Review). In The Cochrane Library. Issue 4. Oxford: Update Software, 2002.
11. Tan BP, Hannah ME. Prostaglandins versus oxytocin for pre-labour rupture of membranes at or near term (Cochrane Library). In The Cochrane Library, Issue 4, Oxford. Update Software, 2002.
12. Kappy KA, Cetrulo C, Knuppel RA et al. Premature rupture of membranes at term: A comparison of induced and spontaneous labors. Journal of Reproductive Medicine 1982; 27: 29-33.
13. Duff P, Huff RW & Gibbs RS. Management of premature rupture of membranes and unfavourable cervix in term pregnancy. Obstetrics and Gynecology 1984; 63: 697-702.
14. Grant JM, Serle E, Mahmood T et al. Management of prelabour rupture of the membranes in term primigravidae: Report of a randomized prospective trial. British Journal of Obstetrics and Gynaecology 1992; 99: 557-562.
15. Chua S, Arulkumaran S, Yap C et al. Premature rupture of membranes in nulliparas at term with unfavourable cervices: A double-blind randomized trial of prostaglandin and placebo. Obstetrics and Gynecology 1995; 86: 550-554.
16. 2 gel. Australia and New Zealand Journal of Obstetrics and Gynaecology 1992; 32: 25-27.
17. 2 gel in term pregnancy with premature rupture of membranes and unfavourable cervix. Journal of the Medical Association of Thailand 1991; 74: 92-96.
18. Hjertberg R, Berg A, Ekman G et al. Twelve or 24 hours expectancy in premature rupture of the membranes (PROM) at term. In 14th European Congress of Perinatal Medicine. 1994: abstract 408.
19. Mahmood TA, Dick MJW, Smith NC & Templeton AA. Role of prostaglandin in the management of prelabour rupture of the membranes at term. British Journal of Obstetrics and Gynaecology 1992; 99: 112-117.
20. Mahmood TA & Dick MJW. A randomized trial of management of pre-labor rupture of membranes at term in multiparous women using vaginal prostaglandin gel. Obstetrics and Gynecology 1995; 85: 71-74.
21. Van Der Walt D & Venter PF. Management of term pregnancy with premature rupture of the membranes and unfavourable cervix. South African Medical Journal 1989; 75: 54-56.
22. 2 for induction of labour in patients with premature rupture of membranes at term. American Journal of Obstetrics and Gynecology 1992; 166: 836-843.
23. 2 for induction of labor in patients with premature rupture of membranes and an unripe cervix. American Journal of Perinatology 1994; 11: 436-438.
24. 2 gel in term pregnancies with premature rupture of membranes. In Proceedings of 12th European Congress of Perinatal Medicine, Lyon, France, 1990: Lyon, France, 1990: 197.
25. Davies NJ, Martindale E & Haddad NG. Cervical ripening with oral prostaglandin E2 tablets and the effect of the latent period in patients with premature rupture of the membranes at term. Journal of Obstetrics and Gynaecology 1991; 11: 405-408.
26. 2 after premature rupture of the membranes at term. Obstetrics and Gynecology 1977; 49: 523-526.
27. Van Heerden J, Steyn DW. Management of premature rupture of membranes after 34 weeks gestation. In Proceedings of the 11th Conference on Priorities in Perinatal Care in South Africa, Caledon, South Africa. 1992.
28. Ngai SW, To WK, Lao T & Ho PC. Cervical priming with oral misoprostol in pre-labor rupture of membranes at term. Obstetrics and Gynecology 1996; 87: 923-926.
29. Chua S, Arulkumaran S, Kurup A et al. Does prostaglandin confer significant advantage over oxytocin infusion for nulliparas with pre-labor rupture of membranes at term? Obstetrics and Gynecology 1991; 77: 664-667.
30. 2 gel in women with unripe cervices and premature rupture of the membranes. Obstetrics and Gynecology 1985; 66: 307-310.
31. 2) tablets and intravenous oxytocin in induction of labour in patients with premature rupture of membranes before 37 weeks of pregnancy. International Journal of Gynecology and Obstetrics 1990; 33: 115-119.
32. 2 gel or intravenous oxytocin. American Journal of Perinatology 1989; 6: 181-184.
33. Lange AP, Secher NJ, Nielsen FH & Pedersen GT. Stimulation of labour in cases of premature rupture of the membranes at or near term. Acta Obstetrica et Gynecologica Scandinavica 1981; 60: 207-210.
34. 2α on labour after spontaneous and artificial rupture of the membranes. Australia and New Zealand Journal of Obstetrics and Gynaecology 1980; 20: 87-90.
35. 2 pessaries with intravenous oxytocin for the stimulation of labour after spontaneous rupture of the membranes. British Journal of Obstetrics and Gynaecology 1983; 90: 726-731.
36. 2 tablets with intravenous oxytocin for stimulation of labour after premature rupture of membranes at term. Acta Obstetrica et Gynecologica Scandinavica 1988; 67: 703-709.
37. McQueen D, Neilson JP & Whittle MJ. Pre-labour rupture of membranes with an unripe cervix: A random trial of management. Journal of Obstetrics and Gynaecology 1990; 10: 495-498.
38. 2α-infusion for stimulation of labour after primary rupture of membranes. Acta Obstetrica et Gynaecologica Scandinavica 1987; 66: 103-106.
39. Rymer J & Parker A. Comparison of syntocinon infusion with prostaglandin vaginal pessaries when spontaneous rupture of the membranes occurs without labour after 34 weeks gestation. Australia and New Zealand Journal of Obstetrics and Gynaecology 1992; 32: 22-24.
40. 1) or intravenous oxytocin. American Journal of Obstetrics and Gynecology 1994; 170. abstract 377.
41. Westergaard JG, Lange AP, Pedersen GT & Secher NJ. Use of oral oxytocics for stimulation of labour in cases of premature rupture of the membranes at term. Acta Obstetrica et Gynaecologica Scandinavica 1983; 62: 111-116.
42. Gafni A, Goeree R, Myhr TL, for the TERM PROM Study Group et al. Induction of labour versus expectant management for prelabour rupture of the membranes at term: An economic evaluation. Canadian Medical Association Journal 1997; 157: 1519-1525.
43. Hofmeyr GJ, Gulmezoglu AM. Vaginal misoprostol for cervical ripening and labour induction in late pregnancy (Cochrane Review). In The Cochrane Library, Issue 4. Oxford: Update Software, 2002.
44. Alfirevic Z, Howarth G, Gausmann A. Oral misoprostol for induction of labour with a viable fetus (Cochrane Review). In The Cochrane Library, Issue 4. Oxford: Update Software, 2002.
45. Young DC, Crane JMG, Hutchens D et al. Misoprostol use in pregnancy: An update. Journal of the Society of Obstetricians and Gynaecologists of Canada 1999; 21: 239-245.
46. Wing DA. Labor induction with misoprostol. American Journal of Obstetrics and Gynecology 1999; 181: 339-345.
47. Hofmeyr GJ, Gulmezoglu AM & Alfirevic Z. Misoprostol for induction of labour: A systematic review. British Journal of Obstetrics and Gynaecology 1999; 106: 798-803.
48. Sanchez-Ramos L, Kaunitz AM, Wears RL et al. Misoprostol for cervical ripening and labor induction: A meta-analysis. Obstetrics and Gynecology 1997; 89: 833-842.
49. Sanchez-Ramos L & Kaunitz AM. Misoprostol for cervical ripening and labor induction: A systematic review of the literature. Clinical Obstetrics and Gynecology 2000; 43: 475-488.
50. Crane J, Leduc L, Farine D et al. Induction of labour at term - SOGC Clinical Practice Guideline. Journal of Obstetrics and Gynaecology Canada 2001; 107: 717-728.
51. Windrim R, Bennett K, Mundle W & Young DC. Oral administration of misoprostol for labor induction: A randomized controlled trial. Obstetrics and Gynecology 1997; 89: 392-397.
52. Bennett KA, Butt K, Crane JMG et al. A masked randomized comparison of oral and vaginal administration of misoprostol for labor induction. Obstetrics and Gynecology 1998; 92: 481-486.
53. Butt KD, Bennett KA, Crane JMG et al. Randomized comparison of oral misoprostol and oxytocin for labor induction in term prelabor membrane rupture. Obstetrics and Gynecology 1999; 94: 994-999.
54. Wing DA, Ham D & Paul RH. A comparison of orally administered misoprostol with vaginally administered misoprostol for cervical ripening and labor induction. American Journal of Obstetrics and Gynecology 1999; 180: 1155-1160.
55. Wing DA, Park MR & Paul RH. A randomized comparison of oral and intravaginal misoprostol for labor induction. Obstetrics and Gynecology 2000; 95: 905-908.
56. Adair CD, Weeks JW, Barrilleaux X et al. Oral or vaginal misoprostol administration for induction of labor: A randomised, double-blind trial. Obstetrics and Gynecology 1998; 92: 810-813.
57. Dyar TR, Greig P, Cummings R & Nichols K. The efficacy and safety or oral versus vaginal misoprostol for the induction of term labour. American Journal of Obstetrics and Gynecology 2000; 182: S135. abstract.
58. Shetty A, Danielian P & Templeton A. A comparison of oral and vaginal misoprostol tablets in the induction of labour at term. British Journal of Obstetrics and Gynaecology 2001; 108: 238-243.
59. Toppozada MK, Anwar MYM, Hassan HA & El-Gazaerly WS. Oral or vaginal misoprostol for induction of labour. International Journal of Gynecology and Obstetrics 1997; 56: 135-139.
60. Ngai SW, Chan YM, Lam SW & Las TT. Labour characteristics and uterine activity: Misoprostol compared with oxytocin in women at term with prelabour rupture of the membranes. British Journal of Obstetrics and Gynaecology 2000; 107; 222-227.
61. Mozurkewich E, Horrocks J, Daley S et al. The misoPROM study: A randomized controlled trial of misoprostol for premature rupture of membranes at term. American Journal of Obstetrics and Gynecology 2002; 187. abstract 398.
62. Crane J, Delaney T & Hutchens D. Oral misoprostol labor induction in term prelabor membrane rupture. American Journal of Obstetrics and Gynecology 2002; 187. abstract 397.
63. Pearson M, Hollier L, Shar A & Yeomans E. A randomized comparison or oral misoprostol versus intravenous oxytocin for induction of labor with term premature rupture of membranes. American Journal of Obstetrics and Gynecology 2002; 187. abstract 424.
64. Shetty A, Stewart K, Stewart G et al. Active management of term prelabour rupture of membranes with oral misoprostol. British Journal of Obstetrics and Gynaecology 2002; 109: 1354-1358.
65. Sanchez-Ramos L, Chen AH, Kaunitz AM et al. Labor induction with intravaginal misoprostol in term premature rupture of membranes: A randomized study. Obstetrics and Gynecology 1997; 89: 902-912.
66. Wing DA & Paul RH. Induction of labor with misoprostol for premature rupture of membranes beyond thirty-six weeks gestation. American Journal of Obstetrics and Gynecology 1998; 179: 94-99.
67. 2 gel versus misoprostol for cervical ripening in patients with premature rupture of membranes after 34 weeks. Obstetrics and Gynecology 2002; 99: 206-210.
68. 2α) for induction of labour at term (Cochrane Review). In Cochrane Library, Issue 4. Oxford: Update Software, 2002.
69. 2. Acta Obstetrica et Gynaecologica Scandinavica 1992; 71: 201-206.
70. Murphy AJ, Jallard M, Pepperell RJ & Quinn MA. Use of vaginal prostaglandin gel before induction of labour. Australia and New Zealand Journal of Obstetrics and Gynaecology 1980; 20: 84-86.
71. 2α for cervical ripening and the induction of labour. Australia and New Zealand Journal of Obstetrics and Gynaecology 1980; 20: 80-83.
72. Roach VJ & Rogers MS. Pregnancy outcome beyond 41 weeks gestation. International Journal of Gynecology and Obstetrics 1997; 59: 19-24.
73. Cardozo L, Fysh J & Pearce JM. Prolonged pregnancy: The management debate. British Medical Journal 1986; 293: 1059-1063.
74. 2 gel and membrane stripping. Journal of Maternal Fetal Medicine 1997; 6: 71-78.
75. Magann EF, Chauhan SP, Mobley JA et al. Risk factors for secondary arrest of labour among women >41 weeks' gestation with an unfavourable cervix undergoing membranes sweeping for cervical ripening. International Journal of Gynecology and Obstetrics 1999; 65: 1-5.
76. Bortolus R. Determinants of response to intracervical prostaglandin for cervical ripening. European Journal of Obstetrics, Gynecology and Reproductive Biology 1999; 87: 137-141.
77. McGuinness BJ & Trivedi AN. Maternal height as a risk factor for Caesarean section due to failure to progress in labour. Australia and New Zealand Journal of Obstetrics and Gynaecology 1999; 39: 152-154.
78. Lange AP, Sercher NJ, Westergaard JG et al. Prelabor evaluation of inducibility. Obstetrics and Gynecology 1982; 60: 137-147.
79. Watson WJ, Stevens D, Walter S & Day D. Factors predicting successful labor induction. Obstetrics and Gynecology 1996; 88: 990-992.
80. Williams MC, Krammer J & O'Brien WF. The value of the cervical score in predicting successful outcome of labor induction. Obstetrics and Gynecology 1997; 90: 784-789.
81. Riskin-Mashiah S & Wilkins I. Cervical ripening. Obstetrics and Gynecology Clinics of North America 1999; 26: 243-257.
82. Xenakis EMJ, Piper JM, Conway DL & Langer O. Induction of labor in the nineties: Conquering the unfavourable cervix. Obstetrics and Gynecology 1997; 90: 235-239.
83. Poma PA. Cervical ripening - A review and recommendation for clinical practice. Journal of Reproductive Medicine 1999; 44: 657-668.
84. Ramsey PS, Ramin KD & Ramin SM. Labor induction. Current Opinion in Obstetrics and Gynecology 2000; 12: 463-473.
85. Bishop EH. Pelvic scoring for elective induction. Obstetrics and Gynecology 1964; 24: 266-268.
86. Edwards RK & Richards DS. Preinduction cervical assessment. Clinical Obstetrics and Gynecology 2000; 43: 440-446.
87. Arulkumaran S, Gibb DMF, Tamby Raja RL et al. Failed induction of labour. Australia and New Zealand Journal of Obstetrics and Gynaecology 1985; 25: 190-193.
88. Chandra S, Crane JMG, Hutchens D & Young DC. Transvaginal ultrasound and digital examination in predicting successful labor induction. Obstetrics and Gynecology 2001; 98: 2-6.
89. Egarter CH, Kofler E, Fitz R & Husselein P. Is induction of labor indicated in prolonged pregnancy? Results of a prospective randomised trial. Gynecology and Obstetric Investigation 1989; 27: 6-9.
90. 2 vaginal suppository. American Journal of Obstetrics and Gynecology 1981; 141: 158-162.
91. 2 production. Acta Obstetrica et Gynaecologica Scandinavica 1990; 69: 621-625.
92. Induction of Labour. Evidence-based Clinical Guideline Number 9, Clinical Effectiveness Support Unit. Royal College of Obstetricians and Gynaecologists. London: RCOG Press, 2001.
93. 2 pessaries on induction of labor. American Journal of Obstetrics and Gynecology 1998; 148: 621-625.
94. 2 vaginal suppository for induction of labour: An efficient, safe and popular method. European Journal of Obstetrics, Gynecology and Reproductive Biology 1987; 26: 233-238.
95. 2 vaginal suppositories. Obstetrics and Gynecology 1984; 63: 664-668.
96. Kelly AJ, Tan B. Intravenous oxytocin alone for cervical ripening and induction of labour (Cochrane Library). In The Cochrane Library, Issue 4. Oxford: Update Software, 2002.
97. Howarth GGR, Botha DJ. Amniotomy plus intravenous oxytocin for induction of labour (Cochrane Review). In The Cochrane Library, Issue 4. Oxford: Update Software, 2002.
98. Delaney T, Crane JM, Hutchens D et al. Oral misoprostol labor induction in patients with a favourable cervix. American Journal of Obstetrics and Gynecology 2001; 185. abstract 438.